We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$468B
AUM Growth
-$6.98B
Cap. Flow
+$2.33B
Cap. Flow %
0.5%
Top 10 Hldgs %
16.09%
Holding
2,594
New
78
Increased
1,210
Reduced
770
Closed
91

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$1.36B
2
PM icon
Philip Morris
PM
+$1.3B
3
AMZN icon
Amazon
AMZN
+$1.21B
4
SYK icon
Stryker
SYK
+$1.12B
5
AET
Aetna Inc
AET
+$1.08B

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$1.46B
2
GILD icon
Gilead Sciences
GILD
+$1.1B
3
DIS icon
Walt Disney
DIS
+$866M
4
AKAM icon
Akamai
AKAM
+$703M
5
CMG icon
Chipotle Mexican Grill
CMG
+$647M

Sector Composition

Rank Sector Weight
1 Healthcare 20.69%
2 Consumer Discretionary 15.01%
3 Financials 13.64%
4 Technology 12.55%
5 Industrials 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGYP
2351
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$142K ﹤0.01%
51,600
+15,900
+45% +$57.6K
CWST icon
2352
Casella Waste Systems
CWST
$5.76B
$140K ﹤0.01%
20,875
TRVN
2353
DELISTED
Trevena, Inc.
TRVN
$140K ﹤0.01%
27
-89
-77% -$448K
BOOM icon
2354
DMC Global
BOOM
$155M
$139K ﹤0.01%
21,500
+9,100
+73% +$55.6K
VHC icon
2355
VirnetX Holding Corp
VHC
$65.8M
$138K ﹤0.01%
+1,500
New +$139K
BEAT
2356
DELISTED
BioTelemetry, Inc.
BEAT
$138K ﹤0.01%
11,800
CBR
2357
DELISTED
CIBER Inc.
CBR
$136K ﹤0.01%
64,540
KE
2358
Kimball Electronics
KE
$606M
$135K ﹤0.01%
12,092
XCRA
2359
DELISTED
Xcerra Corporation
XCRA
$132K ﹤0.01%
20,299
LAND
2360
Gladstone Land Corp
LAND
$353M
$130K ﹤0.01%
12,900
RAS
2361
DELISTED
RAIT Financial Trust
RAS
$130K ﹤0.01%
41,400
RPXC
2362
DELISTED
RPX Corporation
RPXC
$129K ﹤0.01%
11,500
SSRG
2363
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
$129K ﹤0.01%
13,100
GNE icon
2364
Genie Energy
GNE
$380M
$128K ﹤0.01%
16,842
IMMR icon
2365
Immersion
IMMR
$247M
$128K ﹤0.01%
15,500
AVTA
2366
DELISTED
Avantax, Inc. Common Stock
AVTA
$128K ﹤0.01%
24,750
GLF
2367
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$128K ﹤0.01%
20,800
SXC icon
2368
SunCoke Energy
SXC
$801M
$127K ﹤0.01%
+19,500
New +$82.9K
FBP icon
2369
First Bancorp
FBP
$4.46B
$126K ﹤0.01%
43,300
KPTI icon
2370
Karyopharm Therapeutics
KPTI
$46M
$124K ﹤0.01%
927
OVV icon
2371
Ovintiv
OVV
$17.5B
$124K ﹤0.01%
4,040
ARWR icon
2372
Arrowhead Research
ARWR
$12.3B
$123K ﹤0.01%
25,600
PCTI
2373
DELISTED
PCTEL, Inc. Common Stock
PCTI
$123K ﹤0.01%
25,700
CTLP
2374
DELISTED
Cantaloupe
CTLP
$122K ﹤0.01%
28,000
DRRX
2375
DELISTED
DURECT Corp
DRRX
$122K ﹤0.01%
9,053
+127
+1% +$1.62K

Similar funds

T. Rowe Price Associates's Q1 2016 Portfolio in Review

As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
  • T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
  • T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
  • T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
  • T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
  • T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.

Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.